USE OF NON-PEPTIDE NK1 ANTAGONISTS IN A PREDETERMINED DOSE FOR THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

SERVICIO ANDALUZ DE SALUD

发明人:

Manuel Vicente SALINAS MARTÍN

申请号：

US16578934

公开号：

US20200121689A1

申请日:

2019.09.23

申请国别(地区):

US

年份:

2020

代理人:

摘要：

Use of the non-peptide NK1 receptor antagonist, preferably Aprepitant, for the treatment of cancer in predetermined doses. The present invention also describes pharmaceutical compositions comprising said agents, alone or in combination with at least one other active principle, for the treatment of cancer

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/